Esquizofrenia y trastornos afectivos
Charité
Berlín, AlemaniaPublicaciones en colaboración con investigadores/as de Charité (1)
2019
-
Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study
American Journal of Psychiatry, Vol. 176, Núm. 6, pp. 428-438